« Previous
Next »
Journal of Vascular Surgery
Volume 51, Issue 3
, Pages 600-609
, March 2010
Efficacy and safety of alfimeprase in patients with acute peripheral arterial occlusion (PAO)
References
- . Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. Ann Surg. 1994;220:251–268
- Results of a prospective, randomized trial of surgery versus thrombolysis for occluded lower extremity bypass grafts. Am J Surg. 1996;172:105–112
- . A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. N Engl J Med. 1998;338:1105–1111
- . Alfimeprase for the treatment of acute peripheral arterial occlusion. Expert Opin Biol Ther. 2008;8:683–689
- . Nonclinical and clinical characterization of a novel acting thrombolytic: alfimeprase. Pathophysiol Haemost Thromb. 2005;34:215–220
- . Treatment for acute limb ischemia. J Vasc Surg. 2000;31:S160–S173
- . The randomization and stratification of patients to clinical trials. J Chronic Dis. 1974;27:365–375
- A phase I trial of alfimeprase for peripheral arterial thrombolysis. J Vasc Intervent Radiol. 2005;16:1075–1083
- Ouriel K, Cynamon J, Pinto D. Safety and activity of alfimeprase for catheter-directed thrombolysis in patients with lower extremity, acute peripheral arterial occlusion: report of a phase 2, multi-center, multi-national, open-label, dose-escalation study (NAPA-1). Presented at Transcatheter Cardiovascular Therapeutics Symposium 2004, Washington DC, 9/30/2004.
- A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia. J Vasc Surg. 1994;19:1021–1030
- . Surgical revascularization versus thrombolysis for nonembolic lower extremity native artery occlusions: results of a prospective randomized trial. J Vasc Surg. 1996;24:513–523
- . Measurement of walking endurance and walking velocity with questionnaire: validation of the walking impairment questionnaire in men and women with peripheral arterial disease. J Vasc Surg. 1998;28:1072–1081
Competition of interest: Mr Joing was an employee of ARCA biopharma, Inc (formerly named Nuvelo, Inc) at the time of the study.
The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a competition of interest.
PII: S0741-5214(09)01698-X
doi: 10.1016/j.jvs.2009.08.053
© 2010 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Vascular Surgery
Volume 51, Issue 3
, Pages 600-609
, March 2010
